News | June 10, 2024
Neuland unveils refreshed brand identity
The new brand identity embodies Neuland's unwavering commitment to innovation, integrity, collaboration, and progress
The new brand identity embodies Neuland's unwavering commitment to innovation, integrity, collaboration, and progress
Ashkenazi will continue to serve at full capacity in her role and as a member of Lilly's Executive Committee through July 2024
The Gavi Board today approved the Vaccine Alliance's strategy for the five-year period running from 2026 to 2030
DurA Cycle is designed for large-scale commercial manufacturing of monoclonal antibodies,
Innovative technologies and comprehensive services to strengthen Syntegon’s strategic growth
Dr. Reddy's Laboratories gets Form 483 from USFDA with 4 observations for API facility
This strategic decision will unlock significant value for our scientific and industrial products business
Oligonucleotides are a unique modality with potential to address hard-to-treat diseases with high unmet need
Shelter Pharma Limited secured an order from Berlin International Medical Co D3Cure 50 ml x 30000 pcs
Vonoprozan is a novel potassium-competitive acid blocker used for the treatment of acid related disorders
Subscribe To Our Newsletter & Stay Updated
